|
SETD1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.27009999687056E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24389999967001E-07 |
| Normal-vs-Stage2 |
3.636800E-04 |
| Normal-vs-Stage3 |
6.27840002209723E-09 |
| Normal-vs-Stage4 |
1.20739999998065E-06 |
| Stage1-vs-Stage2 |
6.367000E-01 |
| Stage1-vs-Stage3 |
2.171000E-01 |
| Stage1-vs-Stage4 |
5.134000E-01 |
| Stage2-vs-Stage3 |
1.803030E-01 |
| Stage2-vs-Stage4 |
3.385200E-01 |
| Stage3-vs-Stage4 |
7.784000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.6547000042676E-08 |
| Normal-vs-AfricanAmerican |
4.559700E-03 |
| Normal-vs-Asian |
9.90789999999464E-05 |
| Caucasian-vs-AfricanAmerican |
4.538000E-01 |
| Caucasian-vs-Asian |
4.480200E-01 |
| AfricanAmerican-vs-Asian |
7.657000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95050000040276E-07 |
| Normal-vs-Female |
6.47650000296096E-09 |
| Male-vs-Female |
7.539600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.05370004020034E-09 |
| Normal-vs-Age(41-60Yrs) |
2.8250000000396E-06 |
| Normal-vs-Age(61-80Yrs) |
2.02580000552288E-08 |
| Normal-vs-Age(81-100Yrs) |
8.0104999999997E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.910600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.802200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.319600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.324600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.309800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.589400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.1051000003981E-07 |
| Classical-VS-Follicular |
6.966400E-01 |
| Classical-VS-Other |
2.384800E-01 |
| Classical-VS-Normal |
2.94020000002337E-06 |
| Tall-VS-Follicular |
2.441500E-03 |
| Tall-VS-Other |
5.031600E-01 |
| Tall-VS-Normal |
6.86417589434996E-12 |
| Follicular-VS-Other |
5.304400E-01 |
| Follicular-VS-Normal |
1.030110E-04 |
| Other-VS-Normal |
5.597700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.03630004156497E-09 |
| Normal-vs-N1 |
1.5404499999927E-05 |
| N0-vs-N1 |
8.335200E-01 |
|
|
